Navigation Links
ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin

Speculation that the Food and Drug Administration will give a nod for the generic version of Vancocin caused shares in ViroPharma to dip by about 33 percent. The rumors of the FDA's changed perspective // strengthened after Laura Alvey, a spokeswoman for the F.D.A said in an e-mail message that the agency had "recently revised the bioequivalence recommendations for oral vancomycin from a clinical trial with bioequivalence endpoints to an in vitro method involving dissolution testing."

Vancocin or vancomycin is used exclusively to treat hospital-acquired bacterial infections caused in the lower digestive tract by the bacterium Clostridium difficile. Basically, the FDA's changed stance means that a clinical trial for generic vancomycin might not be necessary if it dissolves at the same rate as Vancocin. ViroPharma has intimated that it has filed a petition to stay the action with the F.D.A and added that it would file many more petitions to support "vigorous opposition to any approach that does not require rigorous scientific methods to demonstrate a rate and extent of drug release to the site of action consistent with good medicine and science." But analysts at Infinium Capital feel that a generic version of Vancocin could be available by early 2008. "Previously, generic manufacturers may not have been interested in developing this therapeutic due to its low revenue potential; however, with the recent sales growth of 133 percent in 2005, Vancocin is now on the radar screen," an analyst at Infinium Capital, Bernadine Leung, said.
'"/>




Page: 1

Related medicine news :

1. Shares Of AVI BioPharma Drops On Reports Of Disappointing Early Drug Trail
2. Sun Pharma Allots Shares Upon Fccbs Conversion
3. Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr
4. FDA Moves In To Check Listeria
5. Genetic Test for Type II Diabetes Moves Closer
6. Inhaled Insulin Study Moves Ahead
7. Looking Towards More Effective Leukemia Treatment
8. Attitude Towards AIDS Patients – Time For A Change
9. Scientists Awarded Appropriately For Contribution Towards Medical Research
10. A Step Towards Unraveling The Schizophrenia And Depression Mystery
11. Are Women Not Hearty Enough Towards Seeking Heart Care?
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ViroPharma Shares Fall FDA Moves Towards Generic Vancocin

(Date:6/30/2015)... ... June 30, 2015 , ... ... As a subcontractor, ESSC ranked as one of their top 20 installing dealers ... last quarter of 2014. Providers are based on timeliness, service, installation, paperwork and ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Ticket Down announces that they have slashed prices ... the legendary Pantages Theatre. For the past 26 years, “The Phantom of the ... 1988, this musical, originally written by Gaston Leroux, and converted into a musical by Andrew ...
(Date:6/30/2015)... ... ... Down is a reliable source for last minute tickets for The Rolling Stones at ... North America in conjunction with their 2015 “Zip Code Tour.” , The Stones have been ... their twenties. Some of the most beloved songs that this iconic group has performed ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... Texas have launched a ‘responsive design’ website to inform potential sinus surgery patients ... them. , The website includes information about a wide variety of ENT issues ...
(Date:6/30/2015)... ... 30, 2015 , ... The Blue Cross and Blue Shield of Minnesota Foundation ... state. The projects improve community health by focusing on the social and economic factors ... renewable for a second year in 2016 based on progress in 2015. , “We ...
Breaking Medicine News(10 mins):Health News:Electronic Security Specialists (E.S.S.C. Inc) Awarded Top Service Provider Award By Monitronics 2Health News:Phantom of the Opera Tickets at The Pantages Theatre in Los Angeles: Ticket Down Has Slashed Prices On All Phantom of the Opera Tickets in LA at The Pantages Theatre 2Health News:The Rolling Stones Tickets in Raleigh at Carter Finley Stadium: Ticket Down Offers Last Minute Tickets for the Rolling Stones and Avett Brothers in Raleigh 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 2Health News:Clear Lake Medical Center ENT Launches ‘Responsive Design’ Website 3Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2
... gift of your time with kids is one option to ... physical development should be important considerations when you,re looking for ... the Sciences in Philadelphia. , "Parents often feel like ... moment," Paula Kramer, chairman and professor of occupational therapy, said ...
... many Australians, from the elderly to the very active, restricting the ... all natural arthritis treatment called Mobicosa to help combat this by ... ... Melbourne, VIC (PRWEB) December 18, 2008 -- Arthritis and stiff ...
... Inc. (Amex: BUF ) today reported that ... US LLC (the "Exchange") stating that a review of ... 2008, indicated the Company was not in compliance with ... Guide"), namely Section 1003(a)(i), with stockholders, equity of less ...
... Visions, Inc., a premier,event production and audio-visual integration ... was acquired by Interactive Holdings, a leading,communication solutions ... Creative Visions is best known for producing world ... Palace of Versailles, Sydney Opera House,Blenheim Palace and ...
... Pa., Dec. 17 Carla Bluhm, a developmental psychologist and ... Clendenin, Allegheny class of 2007, have recently completed a book ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080220/DC14623 ) , ... the Mirror: Identity and the New Science of Face Transplants" ...
... QUEBEC CITY, Dec. 17 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: ... tests and delivering lab services, today reported financial and ... year ended October 31, 2008. The Company announced a ... the fourth quarter ending October 31, 2008, and a ...
Cached Medicine News:Health News:'Hot' Toys May Not Be the Best Present 2Health News:Patients Benefit From Mobicosa, A Unique, Natural Arthritis Treatment Available At Your Chemist Shop 2Health News:MINRAD Receives Notice of Failure to Satisfy a Continued Listing Rule from NYSE Alternext 2Health News:MINRAD Receives Notice of Failure to Satisfy a Continued Listing Rule from NYSE Alternext 3Health News:Creative Visions Acquired by Interactive Holdings 2Health News:Creative Visions Acquired by Interactive Holdings 3Health News:Psychology of Face Transplants is Subject of New Book by Allegheny College Professor 2Health News:DiagnoCure announces fourth quarter 2008 and year-end results 2Health News:DiagnoCure announces fourth quarter 2008 and year-end results 3Health News:DiagnoCure announces fourth quarter 2008 and year-end results 4Health News:DiagnoCure announces fourth quarter 2008 and year-end results 5Health News:DiagnoCure announces fourth quarter 2008 and year-end results 6Health News:DiagnoCure announces fourth quarter 2008 and year-end results 7
(Date:6/30/2015)... Calif. , June 30, 2015 Velos, ... specialty medicine, continues to grow and add customers who ... 40% of the 62 CTSAs awarded by the National ... research information management. This is among the largest such ... "Our presence in the CTSA community keeps growing as ...
(Date:6/30/2015)... Millar, Inc. , a leader in catheter-based and wireless ... Craig Thummel , President/CEO and member of the ... the Company. The Company also announced its leadership succession ... Management team as his successors. The Board of Directors ... Sales and Marketing, as President, and also a member ...
(Date:6/30/2015)... 2015 Olympus, a global technology leader ... and surgical procedures, among other core businesses, announced ... equipment at no additional charge. Olympus is the ... of guarantee. The service became available to customers ... year. Olympus, Full Service Agreement ...
Breaking Medicine Technology:Velos continues adding CTSA customers - 40% now use Velos products 2Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3
Sleeve extends 3mm beyond end, .90mm (20G) probe, 1.4mm (17G) sleeve...
Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
Ideal for short scleral tunnel and trabecular meshwork incisions...
Rounded tip for even incisions reducing post-op astigmatism...
Medicine Products: